Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of NOK 518.00 million. The enterprise value is 777.95 million.

Market Cap	518.00M
Enterprise Value	777.95M

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Navamedic ASA has 23.98 million shares outstanding.

Current Share Class	23.98M
Shares Outstanding	23.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.09%
Owned by Institutions (%)	52.70%
Float	21.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	18.19
PS Ratio	0.96
PB Ratio	2.47
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	35.35
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.07, with an EV/FCF ratio of -4.45.

EV / Earnings	-20.53
EV / Sales	1.44
EV / EBITDA	24.07
EV / EBIT	72.56
EV / FCF	-4.45

Financial Position

The company has a current ratio of 1.49, with a Debt / Equity ratio of 1.49.

Current Ratio	1.49
Quick Ratio	0.72
Debt / Equity	1.49
Debt / EBITDA	9.64
Debt / FCF	-1.78
Interest Coverage	0.55

Financial Efficiency

Return on equity (ROE) is -15.99% and return on invested capital (ROIC) is 1.47%.

Return on Equity (ROE)	-15.99%
Return on Assets (ROA)	1.08%
Return on Invested Capital (ROIC)	1.47%
Return on Capital Employed (ROCE)	1.94%
Revenue Per Employee	12.84M
Profits Per Employee	-902,167
Employee Count	42
Asset Turnover	0.87
Inventory Turnover	3.30

Taxes

In the past 12 months, Navamedic ASA has paid 3.39 million in taxes.

Income Tax	3.39M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.84% in the last 52 weeks. The beta is 0.19, so Navamedic ASA's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	-11.84%
50-Day Moving Average	21.80
200-Day Moving Average	21.92
Relative Strength Index (RSI)	49.88
Average Volume (20 Days)	6,511

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of NOK 539.42 million and -37.89 million in losses.

Revenue	539.42M
Gross Profit	197.97M
Operating Income	10.72M
Pretax Income	-34.50M
Net Income	-37.89M
EBITDA	29.23M
EBIT	10.72M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 51.71 million in cash and 311.66 million in debt, giving a net cash position of -259.95 million or -10.84 per share.

Cash & Cash Equivalents	51.71M
Total Debt	311.66M
Net Cash	-259.95M
Net Cash Per Share	-10.84
Equity (Book Value)	209.67M
Book Value Per Share	n/a
Working Capital	77.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.65 million and capital expenditures -189.36 million, giving a free cash flow of -174.71 million.

Operating Cash Flow	14.65M
Capital Expenditures	-189.36M
Free Cash Flow	-174.71M
FCF Per Share	-7.29

Full Cash Flow Statement

Margins

Gross margin is 36.70%, with operating and profit margins of 1.99% and -7.02%.

Gross Margin	36.70%
Operating Margin	1.99%
Pretax Margin	-6.40%
Profit Margin	-7.02%
EBITDA Margin	5.42%
EBIT Margin	1.99%
FCF Margin	n/a

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.31%
FCF Yield	-33.73%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3